CTNM fundamentals
An in-depth look to Contineum Therapeutics, Inc. operating, investing, and financing activities
CTNM free cash flow for Q3 24 is -6.25 M USD. For 2023, CTNM free cash flow was 18.93 M USD and operating cash flow was 19.35 M USD.
Q4 '22
Q1 '23
Q2 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM